Mayo Clinic Ventures

Mayo Clinic Ventures serves as the dedicated venture capital arm of the world-renowned Mayo Clinic, strategically investing in innovative healthcare companies. Established to advance the commercialization of new technologies and solutions, its primary mission aligns with Mayo Clinic's commitment to patient care, research, and education. The fund seeks to identify and support ventures that have the potential to significantly impact healthcare delivery, improve patient outcomes, and generate financial returns that can be reinvested into Mayo Clinic's core operations.

The firm's investment focus spans a broad spectrum of healthcare innovation, including digital health, medical devices, diagnostics, therapeutics, and healthcare IT. Mayo Clinic Ventures typically targets early-stage to growth-stage companies, participating in rounds from seed to Series C. Beyond providing capital, a key differentiator is the strategic value-add it offers portfolio companies, granting them unparalleled access to Mayo Clinic's vast clinical expertise, research infrastructure, and patient populations. This unique ecosystem allows startups to validate their technologies, conduct clinical trials, and gain invaluable insights from leading medical professionals.

With a robust portfolio comprising over 100 investments, Mayo Clinic Ventures has established itself as a significant player in the healthcare venture landscape. Their typical initial investment ranges from approximately $500,000 to $5 million, reflecting their commitment to fostering promising ventures from their foundational stages. This strategic approach not only aims to accelerate the development of groundbreaking medical innovations but also ensures that Mayo Clinic remains at the forefront of transforming healthcare for the benefit of patients worldwide.